March 23 (Reuters) – Gilead Sciences said on Monday it would buy privately held biotech firm Ouro Medicines in a deal worth up to $2.18 billion.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
March 23 (Reuters) – Gilead Sciences said on Monday it would buy privately held biotech firm Ouro Medicines in a deal worth up to $2.18 billion.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
IE 11 is not supported. For an optimal experience visit our site on another browser. Sen. Markwayne Mullin confirmed as new head of DHS 03:31 Now Playing NTSB says flight…
TOKYO (AP) — Asian benchmarks mostly rebounded Tuesday, echoing cautious relief that swept through Wall Street after President Donald Trump said the United States has talked with Iran about a…
